Jason Weatherald
Overview
Explore the profile of Jason Weatherald including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
1788
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luo J, Pavlov I, Tavernier E, Perez Y, Kharat A, McNicholas B, et al.
JAMA Intern Med
. 2025 Mar;
PMID: 40063016
Importance: The impact of awake prone positioning (APP) on clinical outcomes in patients with COVID-19 and acute hypoxemic respiratory failure (AHRF) remains uncertain. Objective: To assess the association of APP...
2.
Rahaghi F, Humbert M, Hoeper M, White R, Frantz R, Hassoun P, et al.
Lancet Respir Med
. 2025 Feb;
PMID: 39987941
Novel treatments in pulmonary arterial hypertension (PAH) with significant pathophysiological and clinical responses have generated renewed interest in changing the course of the disease and achieving long-term disease control. Historically,...
3.
Dmytriiev K, Stickland M, Weatherald J
Heart Fail Clin
. 2024 Nov;
21(1):51-61.
PMID: 39550080
Pulmonary arterial hypertension (PAH) is a progressive pulmonary vascular disease that has a high impact on patients' quality of life, morbidity and mortality. PAH is characterized by extensive pulmonary vascular...
4.
Weatherald J, Fleming T, Wilkins M, Cascino T, Psotka M, Zamanian R, et al.
Eur Respir J
. 2024 Aug;
64(4).
PMID: 39209468
Clinical trials in pulmonary arterial hypertension (PAH) have led to the approval of several effective treatments that improve symptoms, exercise capacity and clinical outcomes. In phase 3 clinical trials, primary...
5.
Weatherald J, Wen C, Stickland M, Damant R, Smith M, Soril L, et al.
Ann Am Thorac Soc
. 2024 Jul;
21(11):1624-1628.
PMID: 39083677
No abstract available.
6.
Weatherald J, Hemnes A, Maron B, Mielniczuk L, Gerges C, Price L, et al.
Eur Respir J
. 2024 Jul;
64(3).
PMID: 38964779
The clinical classification of pulmonary hypertension (PH) has guided diagnosis and treatment of patients with PH for several decades. Discoveries relating to underlying mechanisms, pathobiology and responses to treatments for...
7.
Budhram B, Zamanian R, Weatherald J
Eur Respir J
. 2024 Jun;
63(6).
PMID: 38942441
No abstract available.
8.
Lam G, Wen C, Ronksley P, Bakal J, Bhutani M, Soril L, et al.
Ann Am Thorac Soc
. 2024 May;
21(9):1281-1288.
PMID: 38820253
Existing work suggests that patients with chronic obstructive pulmonary disease (pwCOPD) presented less frequently to the emergency department and were less likely to be hospitalized during the coronavirus disease (COVID-19)...
9.
Thanh N, Waye A, Stewart D, Weatherald J, Lam G, Stickland M, et al.
Telemed J E Health
. 2024 Apr;
30(7):e2024-e2039.
PMID: 38656126
The COVID-19 pandemic started in Alberta in March 2020 and significantly increased telehealth service use and provision reducing the risk of virus transmission. We examined the change in the number...
10.
Weatherald J, Nathan S, El-Kersh K, Argula R, DuBrock H, Rischard F, et al.
BMJ Open Respir Res
. 2024 Mar;
11(1).
PMID: 38519114
Background: Inhaled treprostinil (iTre) is the only treatment approved for pulmonary hypertension due to interstitial lung disease (PH-ILD) to improve exercise capacity. This post hoc analysis evaluated clinical worsening and...